• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺失增强了肿瘤浸润性CD11b+树突状细胞对CD8+T细胞的交叉呈递。

deletion enhances cross-priming of CD8+ T cells by tumor-infiltrating CD11b+ dendritic cells.

作者信息

Bonner Melissa, Askew David, Sathish Kumar Vrishabhadev, Tomchuck Suzanne L, Eid Saada, Abiff Muta, Myers Jay T, Nguyen Phuong, Garyu Justin W A, Miller Tyler E, Huang Alex Yee-Chen

机构信息

Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.

Department of Pediatrics, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.

出版信息

J Immunother Cancer. 2025 Jun 23;13(6):e011815. doi: 10.1136/jitc-2025-011815.

DOI:10.1136/jitc-2025-011815
PMID:40550569
Abstract

BACKGROUND

Tumor-associated myeloid cells (TAMCs) are an abundant, phenotypically plastic cell population that is critical for initiating a robust antitumor response. To properly combat cancer cells, TAMCs must sense and transduce both soluble and vital biophysical cues imparted by the dense extracellular matrix (ECM) of the tumor microenvironment (TME). Despite ample research enumerating the deleterious effects of a primary tumor's ECM on TAMCs' functionality, few studies have evaluated the contribution of mechanosensitive cation channel(s) underlying these detrimental changes.

METHODS

Our study aimed to evaluate the significance of the mechanosensitive cation channel PIEZO1 in TAMCs' phenotype and effector functionality. To do so, we generated CD11b-conditional knockout mice, orthotopically inoculated them with rhabdomyosarcoma 76-9, an aggressive syngeneic rhabdomyosarcoma cell line, and evaluated tumor burden, pan-immune compartment changes, and intrinsic myeloid and lymphoid transcriptomic and functional changes.

RESULTS

Genetic deletion of in CD11b-expressing cells significantly hindered primary and metastatic tumor burden. Intratumorally, we observe enhanced infiltration of CD11b+ dendritic cells (DCs) and CD8+, but not CD4+, T cells. This phenotype was driven by CD11b+ DCs that have undergone transcriptional changes related to improved antigen presentation and T cell activation. Despite being canonically inefficient cross-presenters in the wildtype state, KO CD11b+ DCs, specifically the cDC2A subpopulation, efficiently cross-prime CD8+ T cells on exposure to exogenous particulate antigens.

CONCLUSIONS

Here, we report for the first time an association between mechanosensation and cross-presentation by cDC2A cells. Our findings may be impactful to improving the continued development of DC vaccines whose success hinges on proper antigen processing and presentation to cytotoxic T cells in the TME.

摘要

背景

肿瘤相关髓样细胞(TAMCs)是一种数量丰富、表型具有可塑性的细胞群体,对启动强大的抗肿瘤反应至关重要。为了有效对抗癌细胞,TAMCs必须感知并转导由肿瘤微环境(TME)致密的细胞外基质(ECM)传递的可溶性和重要生物物理信号。尽管有大量研究列举了原发性肿瘤ECM对TAMCs功能的有害影响,但很少有研究评估这些有害变化背后机械敏感阳离子通道的作用。

方法

我们的研究旨在评估机械敏感阳离子通道PIEZO1在TAMCs表型和效应功能中的重要性。为此,我们构建了CD11b条件性敲除小鼠,将侵袭性同基因横纹肌肉瘤细胞系横纹肌肉瘤76 - 9原位接种到这些小鼠体内,并评估肿瘤负荷、全免疫区室变化以及内在髓样和淋巴样转录组及功能变化。

结果

在表达CD11b的细胞中进行基因敲除显著阻碍了原发性和转移性肿瘤负荷。在肿瘤内,我们观察到CD11b + 树突状细胞(DCs)和CD8 + T细胞(而非CD4 + T细胞)的浸润增强。这种表型是由经历了与改善抗原呈递和T细胞激活相关转录变化的CD11b + DCs驱动的。尽管在野生型状态下通常是低效的交叉呈递细胞,但敲除CD11b的DCs,特别是cDC2A亚群,在接触外源性颗粒抗原时能有效地交叉启动CD8 + T细胞。

结论

在此,我们首次报道了机械感觉与cDC2A细胞交叉呈递之间的关联。我们的发现可能对改善DC疫苗的持续开发具有重要意义,DC疫苗的成功取决于在TME中正确的抗原加工和呈递给细胞毒性T细胞。

相似文献

1
deletion enhances cross-priming of CD8+ T cells by tumor-infiltrating CD11b+ dendritic cells.缺失增强了肿瘤浸润性CD11b+树突状细胞对CD8+T细胞的交叉呈递。
J Immunother Cancer. 2025 Jun 23;13(6):e011815. doi: 10.1136/jitc-2025-011815.
2
Extracellular vesicles derived from mature dendritic cells loaded with cDC1-specific chemokine XCL1 combined with chemotherapy-induced ICD for the treatment of castration-resistant prostate cancer.负载cDC1特异性趋化因子XCL1的成熟树突状细胞衍生的细胞外囊泡联合化疗诱导的免疫原性细胞死亡用于去势抵抗性前列腺癌的治疗。
Cancer Immunol Immunother. 2025 Jun 18;74(8):242. doi: 10.1007/s00262-025-04070-8.
3
IRF4-regulated transcriptional and functional heterogeneity of lung-resident CD11b+ cDC2 subsets during influenza virus infection.流感病毒感染期间,IRF4调节肺驻留CD11b + cDC2亚群的转录和功能异质性。
J Immunol. 2025 May 1;214(5):1032-1045. doi: 10.1093/jimmun/vkaf060.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
5
PMN-MDSCs are responsible for immune suppression in anti-PD-1 treated TAP1 defective melanoma.多形核髓系来源抑制细胞(PMN-MDSCs)在抗程序性死亡蛋白1(PD-1)治疗的TAP1缺陷型黑色素瘤中发挥免疫抑制作用。
Clin Transl Oncol. 2025 Jan 18. doi: 10.1007/s12094-024-03840-7.
6
Axl inhibitor-mediated reprogramming of the myeloid compartment of the tumor microenvironment is influenced by prior targeted therapy treatment.Axl抑制剂介导的肿瘤微环境髓样区室重编程受先前靶向治疗的影响。
Front Immunol. 2025 Jun 5;16:1601420. doi: 10.3389/fimmu.2025.1601420. eCollection 2025.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
8
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
9
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
10
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.欧洲癌症研究与治疗组织(EORTC)癌症贫血患者促红细胞生成蛋白使用指南:2006年更新版
Eur J Cancer. 2007 Jan;43(2):258-70. doi: 10.1016/j.ejca.2006.10.014. Epub 2006 Dec 19.

本文引用的文献

1
Progenitors of distinct lineages shape the diversity of mature type 2 conventional dendritic cells.不同谱系的祖细胞塑造了成熟的 2 型传统树突状细胞的多样性。
Immunity. 2024 Jul 9;57(7):1567-1585.e5. doi: 10.1016/j.immuni.2024.05.007. Epub 2024 May 30.
2
Dendritic cells: the yin and yang in disease progression.树突状细胞:疾病进展中的阴阳。
Front Immunol. 2024 Jan 4;14:1321051. doi: 10.3389/fimmu.2023.1321051. eCollection 2023.
3
Piezo1 facilitates optimal T cell activation during tumor challenge.Piezo1 促进肿瘤挑战过程中 T 细胞的最佳激活。
Oncoimmunology. 2023 Nov 22;12(1):2281179. doi: 10.1080/2162402X.2023.2281179. eCollection 2023.
4
CAR-macrophage versus CAR-T for solid tumors: The race between a rising star and a superstar.嵌合抗原受体巨噬细胞疗法与嵌合抗原受体 T 细胞疗法治疗实体瘤:后起之秀与超级巨星的较量。
Biomol Biomed. 2024 May 2;24(3):465-476. doi: 10.17305/bb.2023.9675.
5
Functional tumor cell-intrinsic STING, not host STING, drives local and systemic antitumor immunity and therapy efficacy following cryoablation.功能性肿瘤细胞内源性 STING,而非宿主 STING,可促进冷冻消融后的局部和全身抗肿瘤免疫及治疗效果。
J Immunother Cancer. 2023 Aug;11(8). doi: 10.1136/jitc-2022-006608.
6
g:Profiler-interoperable web service for functional enrichment analysis and gene identifier mapping (2023 update).用于功能富集分析和基因标识符映射的可互操作网络服务(2023 更新)。
Nucleic Acids Res. 2023 Jul 5;51(W1):W207-W212. doi: 10.1093/nar/gkad347.
7
TAP-ing into the cross-presentation secrets of dendritic cells.树突状细胞交叉呈递秘密的 TAP 技术。
Curr Opin Immunol. 2023 Aug;83:102327. doi: 10.1016/j.coi.2023.102327. Epub 2023 Apr 26.
8
Pediatric Patients with Stage IV Rhabdomyosarcoma Significantly Benefit from Long-Term Maintenance Therapy: Results of the CWS-IV 2002 and the CWS DOK IV 2004-Trials.IV期横纹肌肉瘤患儿从长期维持治疗中显著获益:CWS-IV 2002和CWS DOK IV 2004试验结果
Cancers (Basel). 2023 Mar 30;15(7):2050. doi: 10.3390/cancers15072050.
9
Dendritic cell Piezo1 directs the differentiation of T1 and T cells in cancer.树突状细胞 Piezo1 指导癌症中 T1 和 T 细胞的分化。
Elife. 2022 Aug 22;11:e79957. doi: 10.7554/eLife.79957.
10
Orthotopic and Heterotopic Murine Models of Pancreatic Cancer Exhibit Different Immunological Microenvironments and Different Responses to Immunotherapy.原位和异位胰腺癌细胞小鼠模型表现出不同的免疫微环境,并对免疫治疗有不同的反应。
Front Immunol. 2022 Jul 7;13:863346. doi: 10.3389/fimmu.2022.863346. eCollection 2022.